StockData
UFPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

UFP TECHNOLOGIES INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$293.25+1.58 (+0.54%)

Close on Oct 19, 2026

Market cap
$2.28B
P/E (TTM)
31.6
Dividend yield
–

About Ufp Technologies

Surgical & Medical Instruments & Apparatus, SIC 3841

UFP Technologies, Inc. designs and manufactures single-use and single-patient medical devices and specialized components. The company operates as a contract development and manufacturing partner primarily serving the medical sector, including global medical device manufacturers. Its solutions span niche areas such as minimally invasive surgery, infection prevention, wound care, wearables, orthopedics, interventional procedures, and biopharma. It develops custom-engineered products including robotic surgery drapes, patient comfort products, surgical disposables, catheter dispenser coils, and medical packaging.

The company operates nineteen ISO 13485-certified manufacturing locations, thirteen of which are FDA-registered, with facilities and warehouses located in the Dominican Republic and a site in Newburyport, Massachusetts. As of January 2026, the business employed 4,846 full-time staff and 503 temporary workers. The provided text notes Delaware incorporation and manufacturing facilities, but does not state a headquarters location.

Summary of the business section of Ufp Technologies's latest annual report, written by StockData.

Company profile

Company

Legal name
UFP TECHNOLOGIES INC
Founded
1993
Headquarters
Newburyport, MA
Address
100 Hale Street 01950
Phone
(978) 352-2200
Website
ufpt.com
Employees
4,846, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
GRANT THORNTON LLP, Boston, Massachusetts

Stock & identifiers

Ticker
UFPT
Exchange
Nasdaq
Shares outstanding
8M, Jul 27, 2026
Public float
$1.81B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
914156
CUSIP
902673102
ISIN
US9026731029
LEI
549300RJ8LY41HS70C91
EIN
04-2314970

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
R. Jeffrey BaillyExecutive Chairman, Director178,440
Jason HoltVice President7,878
Mitchell RockPresident39,115
Ronald J. LatailleChief Financial Officer59,417
Ryan K. StaffordSVP Human Resources1,448
Christopher P. LitterioSenior Vice President11,977
Steve CardinVice President5,623
Marc D. KozinDirector24,462
Symeria HudsonDirector927
Cynthia L. FeldmannDirector4,476
Joseph John HassettDirector2,602
Thomas OberdorfDirector13,219
Daniel C. CroteauDirector1,657

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
R. Jeffrey Bailly
$7.65M$8.17M$1.82M$476$113
FY2024
R. Jeffrey Bailly
$5.28M$9.48M$1.27M$525$113
FY2023
R. Jeffrey Bailly
$4.93M$8.41M$1.14M$369$102
FY2022
R. Jeffrey Bailly
$4.30M$6.62M$1.02M$253$83
FY2021
R. Jeffrey Bailly
$2.62M$4.14M$712.18K$151$104
FY2020$1.67M$2.07M$460.44K$94$99

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of January 24, 2026, the Company had a total of 4,846 full-time employees (compared to 4,146 full-time employees as of January 25, 2025) and 503 temporary workers (compared to 189 temporary workers at January 25, 2025).”

Corporate history

Events identified from SEC filings